Andrea N. Crivaro

La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effective encapsulation of therapeutic recombinant enzyme into polymeric nanoparticles as a potential vehicle for lysosomal disease treatment.

Effective encapsulation of therapeutic recombinant enzyme into polymeric nanoparticles as a potential vehicle for lysosomal disease treatment.

Journal: International journal of biological macromolecules

Published: August 14, 2024

Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease.

Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease.

Journal: Molecular genetics and metabolism reports

Published: May 15, 2023

Clostridioides difficile: Characterization of the circulating toxinotypes in an Argentinean public hospital.

Clostridioides difficile: Characterization of the circulating toxinotypes in an Argentinean public hospital.

Journal: Revista Argentina de microbiologia

Published: August 09, 2021

Corrigendum to "Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis" [Molecular Genetics Metabolism 130 (2020) 274-282].

Corrigendum to "Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis" [Molecular Genetics Metabolism 130 (2020) 274-282].

Journal: Molecular genetics and metabolism

Published: August 01, 2020

Unraveling the mystery of Gaucher bone density pathophysiology.

Unraveling the mystery of Gaucher bone density pathophysiology.

Journal: Molecular genetics and metabolism

Published: June 18, 2020

Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis.

Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis.

Journal: Molecular genetics and metabolism

Published: April 14, 2020

Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease.

Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease.

Journal: PloS one

Published: March 08, 2019

In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase.

In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase.

Journal: Bone

Published: January 31, 2017

Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.

Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.

Journal: International journal of molecular sciences

Published: October 17, 2016

XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.

XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.

Journal: Pathology oncology research : POR

Published: April 25, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026